Paysign, Inc. (PAYS)
NASDAQInformation TechnologySpecialty Business ServicesSnapshot 2026-11-04
$15.30+1.12%
Close 2026-11-04 · 1-day change
NASDAQInformation TechnologySpecialty Business ServicesSnapshot 2026-11-04
QuarterlyIQ Insights · PAYS
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | 20.7% |
| Our one-year growth estimate | diamond | 27.8% |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-11-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Growth built into the price is above our model estimate.
The price assumes 7.1 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
Worth watching into the next print: this name is on a run of consecutive earnings misses and its industry peers have been missing lately. A fundamental tilt, not a price call.
Model as of 2026-11-04 · Compared with 13 industry peers
PAYS — earnings miss
Dated 2026-08-05
Results of Operations and Financial Condition. On August 5, 2026, we issued a press release regarding our financial results for the second quarter ended June 30, 2026. A copy of the press release is furnished herewith as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. As provided in General Instruction B-2 of SEC Form 8-K, the information set forth in this Item 2.02, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 o…
Why it matters: The program count grew from 135 in Q1 to 148 in Q2. More active programs can support growth in pharma revenue.
Worry ifPaysign reports fewer than 165 active patient aid programs at Q3 end.
Less concerning ifPaysign reports 165 to 170 active programs at Q3 end, as guided.
Why it matters: Paysign set a Q3 revenue range of $28.5 million to $30.0 million. A result below the low end would break that outlook.
Worry ifQ3 revenue is below $28.5 million, the low end of the company’s stated range.
Less concerning ifQ3 revenue is at least $28.5 million.
Why it matters: More pharma revenue helped lift gross margin in Q2. A lower Q3 margin could signal that this gain is fading.
Worry ifQ3 gross margin is below 61.0%, the low end of the stated range.
Less concerning ifQ3 gross margin is at least 61.0%, within or above the stated range.
Why it matters: Paysign raised its full-year revenue range to $114 million to $117 million. Falling short would undo that raised outlook.
Worry ifReported revenue for full-year 2026 is below $114 million.
Less concerning ifReported full-year 2026 revenue is at least $114 million.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$232 on $10,000 · ±2.3% | How much price usually moves either way. |
| Bad day | $484 loss on $10,000 · 4.8% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $4,239 loss on $10,000 · 42.4% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: The center count fell by 46 over the past year, even as plasma revenue grew. A further drop could weigh on that business.
Worry ifPaysign reports fewer than 561 plasma centers at Q3 end.
Less concerning ifPaysign reports 561 to 563 plasma centers at Q3 end, as guided.